33

DAFTAR PUSTAKA
Abidullah, Hussain H., Shujat A., Kamal Z. and Ullah S., 2013,
Pharmacotherapeutical Study of Peptic Ulcer Disease, Impact Journal, 1 (3),
29–36.
Alfiawati N., 2014, Evaluasi Penggunaan Obat Pada Pasien Tukak Peptik Di
Instalasi Rawat Inap RSUP Dr. Soeradji Tirtonegoro Klaten Tahun 2014,
Skripsi, Fakultas Farmasi, Universitas Muhammadiyah Surakarta, Surakarta.
Alldredge B.K., Corelli R.L., Ernst M.E., Guglielmo B.J., Jacobson P.A., Kradjan
W.A. and Williams B.R., 2013, Gastrointestinal Disorders, Koda-Kimble
and Young’s Applied Therapeutics : The Clinical Use of Drugs, Wolters
Kluwer Lippincott Williams & Wilkins, pp. 669–679.
Al-marsoumi and Jabbo, 2013, Risk factors in perforated peptic ulcer disease :
Incidence and relation to morbidity and mortality, Mustansiriya Medical
Journal, 12 (1), 35–44.
Ansari J.A., 2010, Drug Interaction and Pharmacist, Journal of young
pharmacists : JYP, 2 (3), 326–331.
Avunduk C., 2008, Manual Of Gastroenterology : Diagnosis and Therapy, Fourth
Edition., Wolters Kluwer Lippincott Williams & Wilkins, Philadelphia.
Baxter K., 2008, Stockley’s Drug Interactions, Eighth Edition., Pharmaceutical
Press, London.
Berardi R.R. and Welage L.S., 2008, Pharmacotherapi : A Pathophysiologic
Approach, dalam Gastrointestinal Disorders, Mc-GrawHill, New York, pp.
569–583.
British National Formulary, 2011, British National Formulary 61, dalam
Gastrointestinal System, BMJ Group and the Royal Pharmaceutical, London.
Chan W.H., Khin L.W., Chung Y.F.A. and Wong W.K., 2011, Randomized
Controlled Trial of Standard Versus High-dose Intravenous Omeprazole
After Endoscopic Therapy in High-risk Patients With Acute Peptic Ulcer
Bleeding, British Journal of Surgery Society Ltd, 98(5) Terdapat di:
https://www.ncbi.nlm.nih.gov/pubmed/21305536.
Cipolle R.J., Strand L.M. and Morley P.C., 1998, Pharmaceutical Care Practice,
McGraw-Hill: Health Professsions Division, United States of America.
Cipolle R.J., Strand L.M. and Morley P.C., 2004, Pharmaceutical Care Practice :
The Clinician’s Guide, Second Edition., Mc-GrawHill Companies.
 34

Drug Administration and Control Authority, 2007, National Drug Formulary of

Ethiopia, 5–7. Terdapat di:
http://www.who.int/medicines/areas/coordination/ethiopia_formulary.
Desta Z., Soukhova N. V. and Flockhart D.A., 2001, Inhibition of cytochrome
P450 (CYP450) isoforms by isoniazid: Potent inhibition of CYP2C19 and
CYP3A, Antimicrobial Agents and Chemotherapy, 45 (2), 382–392.
Djojoningrat D., 2001, Dispepsia Fungsional, Dalam Buku Ajar Ilmu Penyakit
Dalam, Balai Penerbit FKUI, Jakarta, pp. 153–157.
Drepper M.D., Spahr L. and Frossard J.L., 2012, Clopidogrel and proton pump
inhibitors -where do we stand in 2012?, World journal of gastroenterology :
WJG, 18 (18), 2161–2171.
Faull R., 2007, Prescribing in Renal Disease, Australian Prescriber, 30 (1), 17–
20.
Food and Drug Administration, 2011, FDA Drug Safety Communication: Low
magnesium levels can be associated with long-term use of Proton Pump
Inhibitor drugs (PPIs), U.S. Department of Health and Human Services
Terdapat di: http://www.fda.gov/Drugs/DrugSafety/ucm245011.htm
[Diakses pada October 16, 2016].
Flockhart, 2001, Methods of Drug Interaction Studies, 5. Terdapat di:
http://www.nihs.go.jp/phar/pdf/DiGlEngFinal011209.
Halczli A. and Woolley A.B., 2013, Medication underdosing and
underprescribing: important issues that may contribute to polypharmacy and
poor outcomes, Formulary Journal Outcomes, 1–4.
Helmyati S., Rahmawati N.F., Purwanto and Yuliati E., 2014, Buku Saku
Interaksi Obat dan Makanan, Gajah Mada University Press, Yogyakarta.
Hirlan, 2001, Gastritis, Dalam Buku Ajar Ilmu Penyakit Dalam, Balai Penerbit
FKUI, Jakarta, pp. 127–131.
Kementrian Kesehatan Republik Indonesia, 2010, Profil Kesehatan Indonesia
Tahun 2009, Kementrian Kesehatan Republik Indonesia, Jakarta.
Kementrian Kesehatan Republik Indonesia, 2011, Pedoman Interpretasi Data
Klinik, Jakarta.
Joenoes N.Z., 2009, Ars Prescribendi : Resep yang Rasional, Airlangga
University Press, Surabaya.
Kigen G., Kimaiyo S., Nyandiko W., Faragher B., Sang E., Beatrice, Jakait, Owen
A., Back D., Gibbons S., Seden K. and Khoo S.H., 2011, Prevalence of
Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large
Kenyan Cohort, PLoS ONE, 6 (2), 2.
 35

Kolesar J. and Vermeulen L., 2016, Top 300 Pharmacy Drug Cards, Mc Graw
Hill Education, New York.
Lacy C.F., Armstrong L.L., Goldman M.P. and Lance L.L., 2009, Drug
Information Handbook, 17th Edition., Lexi-Comp for American Pharmacists
Association.
Lockrey G. and Lim L., 2011, Peptic Ulcer Disease in Older People, Journal of
Pharmacy Practice and Research, 41 (1), 58–60.
Lucida H., Trisnawati R. and Suardi M., 2011, Analisis Aspek Farmakokinetika
Klinik Pasien Gagal Ginjal Pada IRNA Penyakit Dalam RSUP DR. M.
Djamil Padang Fakultas Farmasi Universitas Andalas Padang, Jurnal Sains
dan Teknologi Farmasi, 16 (2), 144–152.
Matsui H., Shimokawa O., Kaneko T., Nagano Y., Rai K. and Hyodo I., 2011,
The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-
induced mucosal injuries in stomach and intestine, J. Clin. Biochem. Nutr, 48
(2), 107–111.
Mohebbi L. and Hesch K., 2009, Stress ulcer prophylaxis in the intensive care
unit, Baylor University Medical Center Proceedings, 22 (4), 373–376.
Neal M.J., 2007, At a Glance : Farmakologi Medis, Edisi Kelima., Penerbit
Erlangga, Jakarta.
Nita Y., 2004, Manajemen Farmasi, Airlangga University Press, Surabaya.
Pharmaceutical Care Network Europe, 2006, PCNE Classification for Drug
Related Problem, Pharmaceutical Care Network Europe Foundation.
Priyanto, 2009, Farmakoterapi & Terminologi Medis, Penerbit : Lembaga Studi
dan Konsultasi Farmakologi (Leskonfi), Jakarta.
Sanusi I.A., 2011, Buku Ajar Gatroenterologi, Edisi Kesatu., InternaPublishing
Pusat Penerbitan Ilmu Penyakit Dalam, Jakarta Pusat.
Setiawati A., 2008, Farmakologi dan Terapi, edisi 5., Departemen Farmakologi
dan Terapeutik Fakultas Kedokteran - Universitas Indonesia, Jakarta.
Siddique R.A.H., 2014, Prevalence of Peptic Ulcer Disease Among the Patients
With Abdominal Pain Attending the Department of Medicine in Dhaka
Medical College Hospital, Bangladesh, IOSR Journal of Dental and Medical
Sciences, 13 (1), 5–9.
Tas I., Ulger B.V., Onder A., Kapan M. and Bozdag Z., 2015, Risk Factors
Influencing Morbidity and Mortality in Perforated Peptic Ulcer Disease,
Turkish Surgical Association.
 36

Tatro D.S., 2012, Drug Interaction Facts 2012: The Authority on Drug
Interactions, Wolters Kluwer Health, California.
Thorsen K., Soreide J.A., Kvaloy J.T., Glomsaker T. and Soreide K., 2013,
Epidemiology of Perforated Peptic Ulcer: Age - and Gender Adjusted
Analysis of Incidence and Mortality, World Journal of Gastroenterology, 19
(3), 347–354.
Vanderhoff B.T. and Tahboub R.M., 2002, Proton pump inhibitors: An update,
American Family Physician, 66 (2), 273–278.
Veterans Affairs Pharmacy Benefits, 2005, Criteria for Use of High-dose Oral
Proton Pump Inhibitors, Terdapat di: http://www.pbm.va.gov [Diakses pada
October 28, 2016].
Wecker L., Crespo L.M., Dunaway G., Faingold C. and Watts S., 2010, Brody’s
Human Pharmacology Molecular to Clinical, Fifth Edition., Mosby Elsevier,
Canada.